Abstract

MotivationTumour heterogeneity is being increasingly recognized as an important characteristic of cancer and as a determinant of prognosis and treatment outcome. Emerging spatial transcriptomics data hold the potential to further our understanding of tumour heterogeneity and its implications. However, existing statistical tools are not sufficiently powerful to capture heterogeneity in the complex setting of spatial molecular biology.ResultsWe provide a statistical solution, the HeTerogeneity Average index (HTA), specifically designed to handle the multivariate nature of spatial transcriptomics. We prove that HTA has an approximately normal distribution, therefore lending itself to efficient statistical assessment and inference. We first demonstrate that HTA accurately reflects the level of heterogeneity in simulated data. We then use HTA to analyze heterogeneity in two cancer spatial transcriptomics datasets: spatial RNA sequencing by 10x Genomics and spatial transcriptomics inferred from H&E. Finally, we demonstrate that HTA also applies to 3D spatial data using brain MRI. In spatial RNA sequencing, we use a known combination of molecular traits to assert that HTA aligns with the expected outcome for this combination. We also show that HTA captures immune-cell infiltration at multiple resolutions. In digital pathology, we show how HTA can be used in survival analysis and demonstrate that high levels of heterogeneity may be linked to poor survival. In brain MRI, we show that HTA differentiates between normal ageing, Alzheimer’s disease and two tumours. HTA also extends beyond molecular biology and medical imaging, and can be applied to many domains, including GIS.Availability and implementationPython package and source code are available at: https://github.com/alonalj/hta.Supplementary information Supplementary data are available at Bioinformatics online.

Highlights

  • This study provides a novel solution for characterizing and statistically assessing spatial heterogeneity

  • Differences in copy number alterations and somatic mutations were observed when assessing different tumour microenvironments: EGFRamplified cancer cells were mainly found in poorly vascularized regions, whereas PDGFRA-amplified cancer cells were observed in VC The Author(s) 2021

  • We have developed a statistical tool that measures the level of spatial heterogeneity—the HeTerogeneity Average index (HTA)

Read more

Summary

Introduction

This study provides a novel solution for characterizing and statistically assessing spatial heterogeneity. There has been growing evidence that phenotypical and clonal heterogeneity may play a crucial role in tumour biology and in affecting cancer progression and treatment outcome (AbdulJabbar et al, 2020; Ma et al, 2020). Cancer cells differ in molecular characteristics such as mutations, gene expression and copy number aberrations. These differences, which define the concept of clonality in tumours, are a potentially detrimental hallmark of cancer. The heterogeneous environment arising from such sub-populations has been mainly investigated through bulk measurements. Bulk measurements lack the spatial dimension, which may harbour potentially critical information. Differences in copy number alterations and somatic mutations were observed when assessing different tumour microenvironments: EGFRamplified cancer cells were mainly found in poorly vascularized regions, whereas PDGFRA-amplified cancer cells were observed in VC The Author(s) 2021.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.